Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 217
Filter
Add more filters

Complementary Medicines
Publication year range
1.
World J Microbiol Biotechnol ; 38(2): 24, 2022 Jan 06.
Article in English | MEDLINE | ID: mdl-34989883

ABSTRACT

The ethanol extracts of 155 different foodstuffs containing medicinal plants were investigated for their biofilm eradication activities against pathogenic bacteria. A combined method of a colorimetric microbial viability assay based on reduction of a tetrazolium salt (WST-8) and a biofilm formation technique on the 96-pins of a microtiter plate lid was used to screen the biofilm eradication activities of foodstuffs. The ethanol extracts of licorice (Glycyrrhiza glabra) showed potent biofilm eradication activities against Streptococcus mutans, Staphylococcus aureus, and Porphyromonas gingivalis. Among the antimicrobial constituents in licorice, glabridin had the most potent eradication activities against microbial biofilms. The minimum biofilm eradication concentration of glabridin was 25-50 µg/ml. Furthermore, the combination of glabridin with ɛ-poly-L-lysine, a food additive, could result in broad biofilm eradication activities towards a wide variety of bacteria associated with infection, including Escherichia coli and Pseudomonas aeruginosa.


Subject(s)
Biofilms/drug effects , Flavonoids/pharmacology , Glycyrrhiza/chemistry , Isoflavones/pharmacology , Phenols/pharmacology , Plant Extracts/pharmacology , Polylysine/pharmacology , Anti-Bacterial Agents/pharmacology , Ethanol , Food Additives , Microbial Sensitivity Tests , Microbial Viability/drug effects , Porphyromonas gingivalis/drug effects , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects , Streptococcus mutans/drug effects
2.
Bioorg Chem ; 119: 105562, 2022 02.
Article in English | MEDLINE | ID: mdl-34952243

ABSTRACT

Alzheimer's disease (AD) is a progressive neurological illness that causes dementia mainly in the elderly. The challenging obstacles related to AD has freaked global healthcare system to encourage scientists in developing novel therapeutic startegies to overcome with the fatal disease. The current treatment therapy of AD provides only symptomatic relief and to some extent disease-modifying effects. The current approach for AD treatment involves designing of cholinergic inhibitors, Aß disaggregation inducing agents, tau inhibitors and several antioxidants. Hence, extensive research on AD therapy urgently requires a deep understanding of its pathophysiology and exploration of various chemical scaffolds to design and develop a potential drug candidate for the treatment. Various issues linked between disease and therapy need to be considered such as BBB penetration capability, clinical failure and multifaceted pathophisiology requires a proper attention to develop a lead candidate. This review article covers all probable mechanisms including one of the recent areas for investigation i.e., lipid dyshomeostasis, pathogenic involvement of P. gingivalis and neurovascular dysfunction, recently reported molecules and drugs under clinical investigations and approved by FDA for AD treatment. Our summarized information on AD will attract the researchers to understand and explore current status and structural modifications of the recently reported heterocyclic derivatives in drug development for AD therapy.


Subject(s)
Alzheimer Disease/drug therapy , Anti-Bacterial Agents/pharmacology , Heterocyclic Compounds/pharmacology , Neuroprotective Agents/pharmacology , Porphyromonas gingivalis/drug effects , Alzheimer Disease/metabolism , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Heterocyclic Compounds/chemical synthesis , Heterocyclic Compounds/chemistry , Humans , Microbial Sensitivity Tests , Molecular Structure , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/chemistry
3.
J Infect Dev Ctries ; 15(11): 1685-1693, 2021 11 30.
Article in English | MEDLINE | ID: mdl-34898497

ABSTRACT

INTRODUCTION: Development of bacterial resistance and antimicrobial side-effect has shifted the focus of research toward Ethnopharmacology. A biologically active compound derived from the plants may increase the effectiveness of antibiotic when used in combination. The present study aims to determine the synergistic antibacterial effect of ethanolic extracts of Punica granatum (pericarp), Commiphora molmol, Azadirachta indica (bark) in combination with amoxicillin, metronidazole, tetracycline, and azithromycin on periodontopathic bacteria: Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola and Aggregatibacter actinomycetemcomitans. METHODOLOGY: Periodontopathic bacterial strains were isolated from the plaque sample that was collected from periodontitis patients and grown under favorable conditions. Susceptibility of bacteria to the antibiotics and extracts was determined by disc diffusion method by measuring the diameter of the inhibition zones. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of plant extracts were evaluated against each bacterium. Synergistic effect of plant extract in combination with antibiotics was tested against each bacterium by measuring the diameter of zone of inhibition (ZOI). RESULTS: Findings revealed that all plant extracts exhibited an inhibitory effects on the proliferation and growth of periodontopathic bacteria. The maximum antibacterial effect was exhibited by C. molmol on P. gingivalis (ZOI = 20 ± 0.55 mm, MIC = 0.53 ± 0.24 mg/mL and MBC = 5.21 ± 1.81 mg/mL) (p < 0.05), meanwhile, no antibacterial activity was exhibited by P. granatum on T. forsythia. Synergistic antibacterial effect was recorded when plant extracts were used in combination with antibiotics. The best synergism was exhibited by P. granatum with amoxicillin against A. actinomycetemcomitans (24 ± 1.00 mm) (p < 0.05). CONCLUSIONS: The synergistic test showed significant antibacterial activity when plant extracts were combined with antibiotics against all the experimented bacteria.


Subject(s)
Anti-Bacterial Agents/pharmacology , Periodontitis/microbiology , Plant Extracts/pharmacology , Aggregatibacter actinomycetemcomitans/drug effects , Anti-Bacterial Agents/therapeutic use , Drug Therapy, Combination , Humans , Microbial Sensitivity Tests , Periodontitis/drug therapy , Plant Extracts/therapeutic use , Porphyromonas gingivalis/drug effects , Tannerella forsythia/drug effects
4.
Food Funct ; 12(21): 10470-10483, 2021 Nov 01.
Article in English | MEDLINE | ID: mdl-34554173

ABSTRACT

Cranberries are widely recognized as a functional food that can promote oral health. However, the high concentration of organic acids in cranberry juice can cause tooth enamel erosion. Electrodialysis with bipolar membrane (EDBM) is a process used for the deacidification of cranberry juice. The present study investigated whether the removal of organic acids (0%, 19%, 42%, 60%, and 79%) from cranberry juice by EDBM affects its antibacterial activity against major periodontopathogens as well as its anti-inflammatory properties in an oral epithelial cell model. A deacidification rate ≥60% attenuated the bactericidal effect against planktonic and biofilm-embedded Aggregatibacter actinomycetemcomitans but had no impact on Porphyromonas gingivalis and Fusobacterium nucleatum. Cranberry juice increased the adherence of A. actinomycetemcomitans and P. gingivalis to oral epithelial cells, but reduced the adherence of F. nucleatum by half regardless of the deacidification rate. F. nucleatum produced more hydrogen sulfide when it was exposed to deacidified cranberry juice with a deacidification rate ≥42% compared to the raw beverage. Interestingly, the removal of organic acids from cranberry juice lowered the cytotoxicity of the beverage for oral epithelial cells. Deacidification attenuated the anti-inflammatory effect of cranberry juice in an in vitro oral epithelial cell model. The secretion of IL-6 by lipopolysaccharide (LPS)-stimulated oral epithelial cells exposed to cranberry juice increased proportionally with the deacidification rate. No such effect was observed with respect to the production of IL-8. This study provided evidence that organic acids, just like phenolic compounds, might contribute to the health benefits of cranberry juice against periodontitis.


Subject(s)
Aggregatibacter actinomycetemcomitans/drug effects , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents/pharmacology , Fusobacterium nucleatum/drug effects , Plant Extracts/pharmacology , Porphyromonas gingivalis/drug effects , Vaccinium macrocarpon/chemistry , Acids/chemistry , Anti-Bacterial Agents/chemistry , Anti-Inflammatory Agents/chemistry , Biofilms , Cells, Cultured , Electrochemical Techniques/methods , Epithelial Cells/drug effects , Fruit and Vegetable Juices , Plant Extracts/chemistry
5.
Carbohydr Polym ; 269: 118276, 2021 Oct 01.
Article in English | MEDLINE | ID: mdl-34294308

ABSTRACT

The guided tissue regeneration technique is an effective approach to repair periodontal defect. However, collagen barrier membranes used clinically lose stability easily, leading to soft tissue invasion, surgical site infection, and failure of osteogenesis. An ideal barrier membrane should possess proper antibacterial, osteoconductive activities, and favorable biodegradation. In this study, zinc oxide nanoparticles were homogeneously incorporated into the chitin hydrogel (ChT-1%ZnO) through one-step dissolution and regeneration method from alkaline/urea solution the first time. The remaining weights of ChT-1%ZnO in 150 µg/mL lysozyme solution was 52% after 5 weeks soaking. ChT-1%ZnO showed statistical antibacterial activities for P. gingivalis and S. aureus at 6 h, 12 h, and 24 h. Moreover, ChT-1%ZnO exhibits osteogenesis promotion in vitro, and it was further evaluated with rat periodontal defect model in vivo. The cemento-enamel junction value in ChT-1%ZnO group is 1.608 mm, presenting a statistical difference compared with no-membrane (1.825 mm) and ChT group (1.685 mm) after 8 weeks postoperatively.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Chitin/therapeutic use , Hydrogels/therapeutic use , Membranes, Artificial , Osteogenesis/drug effects , Periodontal Diseases/drug therapy , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/toxicity , Cell Proliferation/drug effects , Chitin/chemistry , Chitin/toxicity , Female , Guided Tissue Regeneration/methods , Hydrogels/chemistry , Hydrogels/toxicity , Microbial Sensitivity Tests , Periodontal Diseases/pathology , Porphyromonas gingivalis/drug effects , Rats, Wistar , Staphylococcus aureus/drug effects , Tooth/drug effects , Tooth/pathology , Zinc Oxide/chemistry , Zinc Oxide/therapeutic use , Zinc Oxide/toxicity
6.
Nutrients ; 14(1)2021 Dec 28.
Article in English | MEDLINE | ID: mdl-35011011

ABSTRACT

Oral microbes are intimately associated with many oral and systemic diseases. Ongoing research is seeking to elucidate drugs that prevent and treat microbial diseases. Various functions of Alpinia Katsumadai seed extracts have been reported such as their anti-viral, anti-oxidant, anti-inflammatory, anti-puritic, anti-emetic, and cytoprotective effects. Here, we investigated the anti-periodontitis effect of an ethanol extract of Alpinia Katsumadai seeds (EEAKSs) on dental plaque bacteria (DPB)-induced inflammation and bone resorption. DPB and Porphyromonas gingivalis (P. gingivalis) were cultured and lipopolysaccharide (LPS) was extracted. Prostaglandin E2 (PGE2) and cyclooxygenase 2 (COX-2) levels were estimated using ELISA. Cytotoxicity was also verified. Proteases were screened using a protease antibody array method. Osteoclastic bone resorption was also investigated. EEAKSs suppressed P. gingivalis growth on agar plates. LPS prepared from dental plaque bacteria (DPB-LPS) and P. gingivalis (PG-LPS) significantly increased PGE2 and COX2 levels in immortalized gingival fibroblasts (IGFs), immortalized human oral keratinocytes (IHOKs), and RAW264.7 macrophage cells. However, DPB-LPS and PG-LPS-induced PGE2 and COX-2 increases were effectively abolished by EEAKS treatment at non-cytotoxic concentrations. In the protease antibody array, matrix metalloproteinase (MMP)-2, MMP-3, MMP-7, kallikrein 10, cathepsin D, and cathepsin V levels were increased by PG-LPS stimulation. However, increases in protease levels except for cathepsin D were suppressed by EEAKS treatment. In addition, RANKL-induced osteoclast differentiation was significantly inhibited by EEAKS treatment, leading to reductions in resorption pit formation. These results suggest that EEAKSs exerted a beneficial oral health effect to help prevent DPB-mediated periodontal disease.


Subject(s)
Alpinia , Ethanol/pharmacology , Periodontitis/drug therapy , Plant Extracts/pharmacology , Seeds , Animals , Bone Resorption/drug therapy , Bone Resorption/microbiology , Cell Differentiation/drug effects , Cyclooxygenase 2/drug effects , Dental Plaque/drug therapy , Dental Plaque/microbiology , Dinoprostone/metabolism , Humans , Lipopolysaccharides/metabolism , Mice , Osteoclasts/drug effects , Periodontal Diseases/drug therapy , Periodontal Diseases/microbiology , Periodontitis/microbiology , Porphyromonas gingivalis/drug effects , RAW 264.7 Cells , Tooth Resorption/drug therapy , Tooth Resorption/microbiology
7.
PLoS One ; 15(10): e0239316, 2020.
Article in English | MEDLINE | ID: mdl-33031410

ABSTRACT

Porphyromonas gingivalis is the keystone pathogen of periodontitis, a chronic inflammatory disease which causes tooth loss and deterioration of gingiva. Medicinal plants have been traditionally used for oral hygiene and health and might play a role as antibacterial agents against oral pathogens. In this work, we aimed to evaluate the antibacterial activity of plants used for oral hygiene or symptoms of periodontitis against P. gingivalis. We first reviewed the literature to identify plant species used for oral hygiene or symptoms of periodontitis. Then, we cross-checked this species list with our in-house library of plant extracts to select extracts for testing. Antibacterial activity tests were then performed for each plant extract against P. gingivalis, and their cytotoxicity was assessed on HaCaT cells. The selectivity index (SI) was then calculated. A total of 416 plant species belonging to 110 families and 305 genera were documented through our literature search, and 158 plant species were noted as being used by North American Native peoples Once cross-checked with the extracts contained in our library of natural products, 30 matches were identified and 21 were defined as high priority. Of the 109 extracts from 21 plant species selected and tested, 21 extracts from 11 plants had higher than 90% inhibition on P. gingivalis at 64 µg/mL and were further selected for MIC (Minimum Inhibitory Concentration) assays. Out of 21 plant extracts, 13 extracts (7 plant species) had a SI > 10. Pistacia lentiscus fruits showed the best MIC with value of 8 µg/mL, followed by Zanthoxylum armatum fruits/seeds with a MIC of 16 µg/mL. P. lentiscus fruits also showed the highest SI of 256. Most of the extracts tested present promising antibacterial activity and low cytotoxicity. Further testing for biofilm eradication and examination of activity against other dental pathogens and oral commensals should be performed to confirm the potential of these extracts as antibacterial agents. Future work will focus on application of a bioassay-guided fractionation approach to isolating and identifying the most active natural products in the top performing extracts. This study can serve as a basis for their future development as ingredients for oral hygiene products.


Subject(s)
Anti-Bacterial Agents/pharmacology , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Porphyromonas gingivalis/drug effects , Anti-Bacterial Agents/chemistry , Cell Line , Cell Survival/drug effects , Fruit/chemistry , Fruit/metabolism , Humans , Microbial Sensitivity Tests , Oral Health , Pistacia/chemistry , Pistacia/metabolism , Plant Extracts/chemistry , Seeds/chemistry , Seeds/metabolism , Zanthoxylum/chemistry , Zanthoxylum/metabolism
8.
Int J Nanomedicine ; 15: 5377-5387, 2020.
Article in English | MEDLINE | ID: mdl-32848384

ABSTRACT

BACKGROUND: Periodontal pathogenic bacteria promote the destruction of periodontal tissues and cause loosening and loss of teeth in adults. However, complete removal of periodontal pathogenic bacteria, at both the bottom of the periodontal pocket and the root bifurcation area, remains challenging. In this work, we explored a synergistic antibiotic and photothermal treatment, which is considered an alternative strategy for highly efficient periodontal antibacterial therapy. METHODS: Mesoporous silica (MSNs) on the surface of Au nanobipyramids (Au NBPs) were designed to achieve the sustained release of the drug and photothermal antibacterials. The mesoporous silica-coated Au NBPs (Au NBPs@SiO2) were mixed with gelatin methacrylate (GelMA-Au NBPs@SiO2). Au NBPs@SiO2 and GelMA-Au NBPs@SiO2 hybrid hydrogels were characterized, and the drug content and photothermal properties in terms of the release profile, bacterial inhibition, and cell growth were investigated. RESULTS: The GelMA-Au NBPs@SiO2 hybrid hydrogels showed controllable minocycline delivery, and the drug release rates increased under 808 nm near-infrared (NIR) light irradiation. The hydrogels also exhibited excellent antibacterial properties, and the antibacterial efficacy of the antibiotic and photothermal treatment was as high as 90% and 66.7% against Porphyromonas gingivalis (P. gingivalis), respectively. Moreover, regardless of NIR irradiation, cell viability was over 80% and the concentration of Au NBPs@SiO2 in the hybrid hydrogels was as high as 100 µg/mL. CONCLUSION: We designed a new near-infrared light (NIR)-activated hybrid hydrogel that offers both sustained release of antibacterial drugs and photothermal treatment. Such sustained release pattern yields the potential to rapidly eliminate periodontal pathogens in the periodontal pocket, and the photothermal treatment maintains low bacterial retention after the drug treatment.


Subject(s)
Anti-Bacterial Agents/pharmacology , Hydrogels/chemistry , Hydrogels/pharmacology , Porphyromonas gingivalis/drug effects , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacokinetics , Cell Line, Tumor , Cell Survival/drug effects , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/pharmacology , Drug Liberation , Gold/chemistry , Hydrogels/pharmacokinetics , Hydrogels/radiation effects , Lasers , Methacrylates/chemistry , Mice , Minocycline/chemistry , Minocycline/pharmacokinetics , Minocycline/pharmacology , Nanostructures/chemistry , Periodontal Diseases/drug therapy , Periodontal Diseases/microbiology , Phototherapy/methods , Silicon Dioxide/chemistry
9.
J Nat Prod ; 83(7): 2087-2092, 2020 07 24.
Article in English | MEDLINE | ID: mdl-32644811

ABSTRACT

In this study, three new garcinoic acid dimers, δ,δ-bigarcinoic acid (1), δ,δ-bi-O-garcinoic acid (2), and γ,δ-bi-O-garcinoic acid (3), and a new benzophenone derivative, (8E)-4-geranyl-3,5-dihydroxybenzophenone (4), as well as seven known compounds (5-11) were isolated from the seeds of Garcinia kola. The structures of the new compounds were elucidated using MALDI-TOF-MS and spectroscopic data, including 1D and 2D NMR and electronic circular dichroism spectra. All of the isolated compounds were evaluated for their antimicrobial activity against two oral pathogens, Porphyromonas gingivalis and Streptococcus sobrinus. Among them, 4 and δ-garcinoic acid (6) exhibited antimicrobial activity against both of these microorganisms (MICs of 31.3-62.5 µM for P. gingivalis and 15.6-31.3 µM for S. sobrinus). These results indicate that some chemical constituents in G. kola seeds have potential application in the prevention of oral diseases.


Subject(s)
Anti-Bacterial Agents/pharmacology , Benzophenones/pharmacology , Benzopyrans/pharmacology , Garcinia kola/metabolism , Mouth/microbiology , Plant Extracts/pharmacology , Porphyromonas gingivalis/drug effects , Seeds/chemistry , Streptomyces/drug effects , Anti-Bacterial Agents/chemistry , Benzophenones/isolation & purification , Benzopyrans/chemistry , Chromatography, High Pressure Liquid , Humans , Microbial Sensitivity Tests , Spectrum Analysis/methods
10.
Int J Pharm ; 586: 119534, 2020 Aug 30.
Article in English | MEDLINE | ID: mdl-32531451

ABSTRACT

Statins have been proposed as potential adjuvant to periodontal treatment due to their pleiotropic properties. A new thermosensitive chitosan hydrogel loaded with statins (atorvastatin and lovastatin) nanoemulsions was synthesized to allow a spatially controlled local administration of active compounds at lesion site. Spontaneous nano-emulsification method was used to synthesize statins loaded nanoemulsions. In vitro, atorvastatin and lovastatin loaded nanoemulsions were cytocompatible and were able to be uptake by oral epithelial cells. Treatment of Porphyromonas gingivalis infected oral epithelial cells and gingival fibroblasts with atorvastatin and lovastatin loaded nanoemulsions decreased significantly pro-inflammatory markers expression (TNF-α and IL-1ß) and pro-osteoclastic RANKL. Nevertheless, such treatment induced the expression of Bone sialoprotein 2 (BSP2) in osteoblast emphasizing the pro-healing properties of atorvastatin and lovastatin nanoemulsions. In vivo, in a calvarial bone defect model (2 mm), treatment with the hydrogel loaded with atorvastatin and lovastatin nanoemulsions induced a significant increase of the neobone formation in comparison with systemic administration of statins. This study demonstrates the potential of this statins loaded hydrogel to improve bone regeneration and to decrease soft tissue inflammation. Its use in the specific context of periodontitis management could be considered in the future with a reduced risk of side effects.


Subject(s)
Atorvastatin/pharmacology , Bone Regeneration/drug effects , Chitosan/chemistry , Lovastatin/pharmacology , Animals , Atorvastatin/administration & dosage , Cells, Cultured , Epithelial Cells/drug effects , Fibroblasts/drug effects , Fibroblasts/metabolism , Gingiva/cytology , Gingiva/drug effects , Humans , Hydrogels , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Lovastatin/administration & dosage , Male , Mice , Mice, Inbred C57BL , Porphyromonas gingivalis/drug effects
11.
Int J Mol Sci ; 21(7)2020 Apr 01.
Article in English | MEDLINE | ID: mdl-32244806

ABSTRACT

Periodontal diseases are caused by bacterial infection and may progress to chronic dental disease; severe inflammation may result in bone loss. Therefore, it is necessary to prevent bacterial infection or control inflammation. Periodontal ligament fibroblasts (PDLFs) are responsible for the maintenance of tissue integrity and immune and inflammatory events in periodontal diseases. The formation of bacterial complexes by Fusobacterium nucleatum and Porphyromonas gingivalis is crucial in the pathogenesis of periodontal disease. F. nucleatum is a facultative anaerobic species, considered to be a key mediator of dental plaque maturation and aggregation of other oral bacteria. P. gingivalis is an obligate anaerobic species that induces gingival inflammation by secreting virulence factors. In this study, we investigated whether Osmunda japonica extract exerted anti-inflammatory effects in primary PDLFs stimulated by oral pathogens. PDLFs were stimulated with F. nucleatum or P. gingivalis. We showed that pro-inflammatory cytokine (IL-6 and IL-8) expression was induced by LPS or bacterial infection but decreased by treatment with O. japonica extract following bacterial infection. We found that the activation of NF-κB, a transcription factor for pro-inflammatory cytokines, was modulated by O. japonica extract. Thus, O. japonica extract has immunomodulatory activity that can be harnessed to control inflammation.


Subject(s)
Bacterial Infections/prevention & control , Cytokines/antagonists & inhibitors , Fibroblasts/drug effects , Inflammation Mediators/antagonists & inhibitors , NF-kappa B/metabolism , Plant Extracts/pharmacology , Adult , Bacterial Infections/metabolism , Bacterial Infections/microbiology , Cell Survival/drug effects , Cells, Cultured , Cytokines/genetics , Cytokines/metabolism , Down-Regulation/drug effects , Ferns/chemistry , Fibroblasts/metabolism , Fibroblasts/microbiology , Gene Expression Regulation/drug effects , Humans , Inflammation Mediators/metabolism , Periodontal Ligament/cytology , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/physiology
12.
Anaerobe ; 63: 102194, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32205191

ABSTRACT

Being aware of the remarkable antimicrobial potential of S. officinalis L., we aimed to evaluate the antimicrobial activity of the S. officinalis dichloromethane crude extract (SOD), dichloromethane-soluble fractions (SODH and SODD), SODD subfractions (SODD1 and SODD2), and pure substances (manool, salvigenin, and viridiflorol) against periodontopathogens. This bioassay-guided study comprises five antimicrobial tests-determination of the Minimum Inhibitory Concentration (MIC), determination of the Minimum Bactericidal Concentration (MBC), determination of the antibiofilm activity, construction of the Time-kill curve (determination of Bactericidal Kinetics), and determination of the Fractional Inhibitory Concentration Index-on six clinical bacterial isolates and three standard bacterial strains involved in periodontal disease. SOD has moderate activity against most of the tested bacteria, whereas SODD1, SODH1, SODH3, and manool afford the lowest results. The Porphyromonas gingivalis (ATTC and clinical isolate) biofilm is considerably resistant to all the samples. In association with chlorhexidine gluconate, only SODH1 exerts additive action against P. gingivalis (clinical isolate). Therefore, SODH1 and manool are promising antibacterial agents and may provide therapeutic solutions for periodontal infections.


Subject(s)
Aggressive Periodontitis , Anti-Bacterial Agents/pharmacology , Plant Extracts/pharmacology , Salvia officinalis/metabolism , Aggressive Periodontitis/drug therapy , Aggressive Periodontitis/microbiology , Bacteria/drug effects , Biofilms/drug effects , Diterpenes/pharmacology , Humans , Microbial Sensitivity Tests , Mouth/microbiology , Porphyromonas gingivalis/drug effects
13.
Braz. arch. biol. technol ; 63: e20190196, 2020. tab, graf
Article in English | LILACS | ID: biblio-1132166

ABSTRACT

Abstract Endodontic infections result from oral pathogenic bacteria which reach and infect dental pulp, as well as surrounding tissues, through cracks, unrepaired caries and failed caries restorations. This study aims to determine the chemical composition of essential oil from Psidium cattleianum leaves (PC-EO) and to assess its antibacterial activity against endodontic bacteria. Antibacterial activity of PC-EO was evaluated in terms of its minimum inhibitory concentration (MIC) values by the broth microdilution method on 96-well microplates. Bacteria Porphyromonas gingivalis (MIC = 20 µg/mL), Prevotella nigrescens (MIC = 62.5 µg/mL), Fusobacterium nucleatum (MIC = 12.5 µg/mL), Actinomyces naeslundii (MIC = 50 µg/mL), Bacteroides fragilis (MIC = 12.5 µg/mL), Aggregatibacter actinomycetemcomitans (MIC = 6.25 µg/mL) and Peptostreptococcus anaerobius (MIC = 62.5 µg/mL) were evaluated and compared to chlorhexidine dihydrochloride (CDH), the positive control. PC-EO was obtained by hydrodistillation with the use of a Clevenger-type apparatus whereas its chemical composition was analyzed by gas chromatography-flame ionization detection (GC-FID) and gas chromatography-mass spectrometry (GC-MS). Viridiflorol (17.9%), β-caryophyllene (11.8%), 1,8-cineole (10.8%) and β-selinene (8.6%) were the major constituents found in PC-EO, which exhibited high antibacterial activity against all endodontic pathogens under investigation. Therefore, PC-EO, a promising source of bioactive compounds, may provide therapeutic solutions for the field of endodontics.


Subject(s)
Oils, Volatile/pharmacology , Chlorhexidine/pharmacology , Psidium/chemistry , Anti-Bacterial Agents/pharmacology , Peptostreptococcus/drug effects , Bacteroides fragilis/drug effects , Actinomyces/drug effects , Microbial Sensitivity Tests , Fusobacterium nucleatum/drug effects , Aggregatibacter actinomycetemcomitans/drug effects , Porphyromonas gingivalis/drug effects , Prevotella nigrescens/drug effects , Gas Chromatography-Mass Spectrometry
14.
Med Sci Monit ; 25: 7471-7479, 2019 Oct 05.
Article in English | MEDLINE | ID: mdl-31586435

ABSTRACT

BACKGROUND The purpose of the present research is to analyze the effect of polyphenols and flavonoids substrat (PFS) from plants Calendula officinalis, Salvia fruticosa, Achillea millefolium, and propolis as immunomodulatory in the production of interleukin (IL)-1ß and IL-10 in peripheral blood leukocytes medium (PBLM) in patients who were diagnosed with mucositis of peri-implant tissue compared to patients with healthy implant tissue. It was hypothesized that IL-1ß and IL-10 contribute to the inflammation processes noticed in the diseases of peri-implant tissues. MATERIAL AND METHODS Sixty non-smoking patients were included in this study: patients with healthy implants (HP group) and patients with peri-implant mucositis (MP group). Peri-mucositis was diagnosed by radiologic and clinical examination. The PBLM from MP were treated with PFS at various concentrations. The levels of IL-10 and IL-1ß excreted by the PBLM stimulated and unstimulated with viable Porphyromonas gingivalis test-tube were committed by the enzyme amplified immunoassay sensitivity method. RESULTS Unstimulated and stimulated PBLM and treatment with 5.0 mg/mL or 10.0 mg/mL of PFS in the MP group produced significantly higher levels IL-10 (P<0.001) that analogous mediums of the HP group. The levels of IL-1ß decreased more considerably in the stimulated PBLM of the MP group than in those of HP group (P<0.001) after the treatment with PFS at only 10.0 mg/mL concentration. CONCLUSIONS Theses results suggest that the solution of PFS might offer a new potential for the development of a new therapeutic path to prevent and treat peri-implant mucositis.


Subject(s)
Interleukin-10/biosynthesis , Interleukin-1beta/biosynthesis , Leukocytes/immunology , Stomatitis/drug therapy , Achillea/chemistry , Aged , Calendula/chemistry , Camphanes , Dental Implants , Dental Plaque Index , Drugs, Chinese Herbal/pharmacology , Female , Flavonoids/pharmacology , Humans , Interleukin-10/immunology , Interleukin-1beta/immunology , Leukocytes/drug effects , Male , Middle Aged , Mucositis/drug therapy , Panax notoginseng , Peri-Implantitis/metabolism , Periodontal Index , Plant Extracts/pharmacology , Polyphenols/pharmacology , Porphyromonas gingivalis/drug effects , Salvia miltiorrhiza , Stomatitis/blood , Stomatitis/immunology
15.
FEMS Microbiol Lett ; 366(16)2019 08 01.
Article in English | MEDLINE | ID: mdl-31578552

ABSTRACT

Chronic periodontitis is caused by dysbiosis of human oral commensals and especially by increase in Porphyromonas gingivalis. Inhibitors of P. gingivalis growth are expected to serve as effective drugs for the periodontal therapy. In the present study, we isolated new growth inhibitors of P. gingivalis using minimal media for P. gingivalis. The minimal media included the previously reported Globulin-Albumin (GA) and the newly developed Lactalbumin-Ferric chloride (LF) and Globulin-Calcium chloride (GC); all supported growth of the wild-type strain of P. gingivalis but did not support the growth of a mutant defective for a type IX secretion system. GC contains CaCl2, indicating that P. gingivalis requires a calcium ion for growth. Using LF and GA, we screened about 100 000 compounds and identified 73 that strongly inhibited the growth of P. gingivalis. More than half of these candidates would not have been obtained if these minimal media had not been used in our screen. One of our candidate inhibitors was diphenyleneiodonium chloride (DPIC), which showed strong bactericidal activity against P. gingivalis. Excess amounts of flavin adenine dinucleotide or flavin mononucleotide suppressed the inhibitory activity of DPIC, suggesting that DPIC would be a novel potent growth inhibitor.


Subject(s)
Anti-Bacterial Agents/metabolism , Culture Media/chemistry , Dinitrocresols/antagonists & inhibitors , Drug Evaluation, Preclinical/methods , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/growth & development , Microbial Sensitivity Tests/methods , Microbial Viability/drug effects
16.
Nutrients ; 11(9)2019 Sep 16.
Article in English | MEDLINE | ID: mdl-31527555

ABSTRACT

BACKGROUND: Coffee is a major dietary source of polyphenols. Previous research found that coffee had a protective effect on periodontal disease. In this study, we aimed to investigate whether coffee extract and its primary phenolic acid, chlorogenic acid, affect the growth and protease activity of a periodontopathogen Porphyromonas gingivalis (P. gingivalis). METHODS: Coffee extract and chlorogenic acid were prepared by a two-fold serial dilution. The turbid metric test and plate count method were used to examine the inhibitory effects of chlorogenic acid on P. gingivalis. The time-kill assay was used to measure changes in the viability of P. gingivalis after exposure to chlorogenic acid for 0-24 h. The protease activity of P. gingivalis was analyzed using the optical density of a chromogenic substrate. RESULTS: As a result, the minimum inhibitory concentration (MIC) of chlorogenic acid was 4 mg/mL, and the minimum bactericidal concentration was 16 mg/mL. Chlorogenic acid at concentrations above MIC resulted in a longer-lasting inhibitory effect on P. gingivalis viability and significantly reduced associated protease activity. The coffee extract showed antibacterial activity as observed by the disk diffusion test, whereas these inhibitory effects were not affected by different roast degrees of coffee. CONCLUSIONS: Collectively, our novel findings indicate that chlorogenic acid not only has antimicrobial activity but also reduced the protease activity of P. gingivalis. In addition, coffee extract inhibits the proliferation of P. gingivalis, which may partly be attributed to the effect of chlorogenic acid.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteroidaceae Infections/prevention & control , Chlorogenic Acid/pharmacology , Coffea/chemistry , Periodontitis/drug therapy , Plant Extracts/pharmacology , Porphyromonas gingivalis/drug effects , Anti-Bacterial Agents/isolation & purification , Bacterial Proteins/metabolism , Bacteroidaceae Infections/microbiology , Chlorogenic Acid/isolation & purification , Disk Diffusion Antimicrobial Tests , Microbial Viability/drug effects , Peptide Hydrolases/metabolism , Periodontitis/microbiology , Plant Extracts/isolation & purification , Porphyromonas gingivalis/enzymology , Porphyromonas gingivalis/pathogenicity , Seeds/chemistry , Time Factors , Virulence Factors/metabolism
17.
J Food Biochem ; 43(11): e13029, 2019 11.
Article in English | MEDLINE | ID: mdl-31465126

ABSTRACT

Porphyromonas gingivalis is a major periodontitis pathogen that produces several virulence factors including hemagglutinins. These proteins, which are vital molecules, allow P. gingivalis to uptake iron and heme by attaching, aggregating, and lysing erythrocytes. In this study, we evaluated the inhibitory activity of the aqueous extract of Monechma ciliatum seeds against the hemagglutination activity of P. gingivalis. M. ciliatum is a Sudanese medicinal herb that grows in arid and semi-arid lands of tropical Africa. The water extracted from dry powdered seeds was partitioned using ethyl acetate followed by reversed-phase chromatography, thin-layer chromatography, ESI-MS, and NMR analysis resulting in the isolation of four compounds identified as oleic acid, coumarin, 1,2-dioleoylglycerol, and 1,3-dioleoylglycerol with MICs of 15-100 µg/ml against hemagglutination. We believe that the isolation and purification of these compounds will expand the application of M. ciliatum as a natural therapeutic or preventative agent. PRACTICAL APPLICATIONS: Monechma ciliatum or black mahlab is a famous medicinal plant that grows in some parts of arid and semi-arid areas of tropical Africa including western Sudan. Despite its nutritional and traditional medical applications, no studies have evaluated its anti-hemagglutination activity against periodontal pathogens. In this study, four active compounds (oleic acid, coumarin, 1,2-dioleoylglycerol, and 1,3-dioleoylglycerol) were isolated and identified from an aqueous extract of M. ciliatum seeds. The isolated compounds revealed high levels of inhibitory activity against all hemagglutinin agents secreted by Porphyromonas gingivalis. This evidence of inhibitory activity will encourage the application of M. ciliatum effectively as a functional food or therapeutic agent to prevent periodontal diseases in the early stages.


Subject(s)
Acanthaceae/chemistry , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Hemagglutinins/metabolism , Plant Extracts/pharmacology , Porphyromonas gingivalis/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/genetics , Hemagglutination Tests , Hemagglutinins/genetics , Heme/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Porphyromonas gingivalis/genetics , Porphyromonas gingivalis/metabolism , Seeds/chemistry , Sudan
18.
Mol Pharm ; 16(9): 4017-4023, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31361146

ABSTRACT

The in vivo antibacterial activity of NO-releasing hyperbranched polymers was evaluated against Porphyromonas gingivalis, a key oral pathogen associated with periodontitis, using a murine subcutaneous chamber model. Escalating doses of NO-releasing polymers (1.5, 7.5, and 37.5 mg/kg) were administered into a P. gingivalis-infected chamber once a day for 3 days. Chamber fluids were collected on day 4, with microbiological evaluation indicating a dose-dependent bactericidal action. In particular, NO-releasing polymers at 37.5 mg/kg (1170 µg of NO/kg) achieved complete bacterial eradication (>6-log reduction in bacterial viability), demonstrating greater efficacy than amoxicillin (∼4-log reduction in bacterial viability), a commonly used antibiotic. Time-kill assays further revealed that largest dose (37.5 mg/kg; 1170 µg of NO/kg) resulted in ∼3-log killing of P. gingivalis after only a single dose. Based on these results, the potential clinical utility of NO-releasing hyperbranched polymers appears promising, particularly for oral health applications.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/therapeutic use , Bacteroidaceae Infections/drug therapy , Nitric Oxide/chemistry , Nitric Oxide/therapeutic use , Periodontitis/drug therapy , Polymers/chemistry , Porphyromonas gingivalis/drug effects , Amoxicillin/therapeutic use , Animals , Bacteroidaceae Infections/microbiology , Disease Models, Animal , Epoxy Compounds/chemistry , Male , Mice , Mice, Inbred C57BL , Microbial Sensitivity Tests , Microbial Viability/drug effects , Periodontitis/microbiology , Polyamines/chemistry , Treatment Outcome
19.
Int J Mol Sci ; 20(14)2019 Jul 23.
Article in English | MEDLINE | ID: mdl-31340425

ABSTRACT

The aim of this study was to perform a systematic review of the literature followed by a meta-analysis about the efficacy of photodynamic therapy (PDT) on the microorganisms responsible for dental caries. The research question and the keywords were constructed according to the PICO strategy. The article search was done in Embase, Lilacs, Scielo, Medline, Scopus, Cochrane Library, Web of Science, Science Direct, and Pubmed databases. Randomized clinical trials and in vitro studies were selected in the review. The study was conducted according the PRISMA guideline for systematic review. A total of 34 articles were included in the qualitative analysis and four articles were divided into two subgroups to perform the meta-analysis. Few studies have achieved an effective microbial reduction in microorganisms associated with the pathogenesis of dental caries. The results highlight that there is no consensus about the study protocols for PDT against cariogenic microorganisms, although the results showed the PDT could be a good alternative for the treatment of dental caries.


Subject(s)
Bacteroidaceae Infections/drug therapy , Candidiasis/drug therapy , Dental Caries/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Streptococcal Infections/drug therapy , Bacteroidaceae Infections/microbiology , Biofilms/drug effects , Biofilms/growth & development , Candida/drug effects , Candida/growth & development , Candida/pathogenicity , Candidiasis/microbiology , Curcumin/pharmacology , Dental Caries/microbiology , Humans , Methylene Blue/pharmacology , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/growth & development , Porphyromonas gingivalis/pathogenicity , Rosaniline Dyes/pharmacology , Streptococcal Infections/microbiology , Streptococcus/drug effects , Streptococcus/growth & development , Streptococcus/pathogenicity , Tolonium Chloride/pharmacology , Treatment Outcome
20.
Fitoterapia ; 137: 104274, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31344394

ABSTRACT

We have previously demonstrated that out of the butyrolactones series synthesized based on the natural lichen metabolite lichesterinic acid, compound (B-13) was the most effective against oral bacteria. However, its antibacterial mechanism is still unknown. In this study, we have investigated its bacterial localization by synthesizing a fluorescently labeled B-13 with NBD while maintaining its antibacterial activity. We showed that this compound binds to Streptococcus gordonii cell surface, as demonstrated by HPLC analysis. By adhering to cell surface, B-13 induced cell wall disruption leading to the release of bacterial constituents and consequently, the death of S. gordonii, a Gram-positive bacterium. A Gram-negative counterpart, Porphyromanas gingivalis, showed also cracked and ruptured cells in the presence of B-13. Besides, we also demonstrated that the analog of B-13, B-12, has also induced disruption of P. gingivalis and S. gordonii. This study revealed that butyrolactones can be considered as potent antibacterial compounds against oral pathogens causing medical complications.


Subject(s)
Anti-Bacterial Agents/pharmacology , Lactones/pharmacology , Lichens/chemistry , Porphyromonas gingivalis/drug effects , Streptococcus gordonii/drug effects , Cell Membrane/drug effects , Microbial Sensitivity Tests , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL